An update on the medical therapy of advanced metastatic renal cell carcinoma

Medicine and Dentistry

• Clear Cell Renal Cell Carcinoma 100%
• Clinical Study 50%
• Combination Therapy 100%
• Cytokine 50%
• Kidney Metastasis 100%
• Mechanistic Target of Rapamycin 50%
• Phosphotransferase Inhibitor 50%
• Progression Free Survival 50%
• Sorafenib 100%
• Sunitinib 100%
• Temsirolimus 50%
• Vasculotropin 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Study 50%
• Combination Therapy 100%
• Cytokine 50%
• Kidney Metastasis 100%
• Mammalian Target of Rapamycin 50%
• Phosphotransferase Inhibitor 50%
• Progression Free Survival 50%
• Renal Cell Carcinoma 100%
• Sorafenib 100%
• Sunitinib 100%
• Temsirolimus 50%
• Vasculotropin 50%